These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7126997)

  • 1. Effects of lysine-vasopressin and oxytocin on central cardiovascular control.
    Tran LD; Montastruc JL; Montastruc P
    Br J Pharmacol; 1982 Sep; 77(1):69-73. PubMed ID: 7126997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohypophysial peptides and central cardiovascular control.
    Montastruc JL; Dang Tran L; Montastruc P
    Eur Heart J; 1983 Nov; 4 Suppl G():47-50. PubMed ID: 6662121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides.
    Montastruc JL; Dang Tran L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):299-308. PubMed ID: 6486975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of a central hypotensive action of lysine vasopressin in the dog].
    Tran LD; Montastruc JL; Montastruc P
    C R Seances Acad Sci III; 1981 Oct; 293(5):267-9. PubMed ID: 6796210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of vagal pressor reflexes by neurohypophyseal peptides and related compounds.
    Montastruc P; Dang Tran L; Montastruc JL
    Eur J Pharmacol; 1985 Nov; 117(3):355-61. PubMed ID: 4076350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiovascular actions of d-tubocurarine and inhibition of the hypotensive effect of clonidine.
    Tsoucaris-Kupfer D; Liblau L; Legrand M; Schmitt H
    Eur J Pharmacol; 1980 Jul; 65(2-3):301-4. PubMed ID: 7398793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohypophysial peptides and central cardiovascular control in the anaesthetized dog.
    Montastruc JL; Dang Tran L
    Clin Exp Hypertens A; 1984; 6(10-11):1987-91. PubMed ID: 6532583
    [No Abstract]   [Full Text] [Related]  

  • 8. Central cardiovascular effects of acetylcholine in the conscious dog.
    Brefel C; Lazartigues E; Tran MA; Gauquelin G; Geelen G; Gharib C; Montastruc JL; Montastruc P; Rascol O
    Br J Pharmacol; 1995 Oct; 116(4):2175-82. PubMed ID: 8564246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Area postrema lesions augment the pressor activity of centrally administered vasopressin.
    Michelini LC; Barnes KL; Ferrario CM
    Clin Exp Hypertens A; 1986; 8(7):1107-25. PubMed ID: 3769219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central cardiovascular effects induced by intracisternal PACAP in dogs.
    Seki Y; Suzuki Y; Baskaya MK; Saito K; Takayasu M; Shibuya M; Sugita K
    Am J Physiol; 1995 Jul; 269(1 Pt 2):H135-9. PubMed ID: 7631841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-glutamic acid and kainic acid on central cardiovascular control.
    Chelly J; Kouyoumdjian JC; Mouillé P; Huchet AM; Schmitt H
    Eur J Pharmacol; 1979 Nov; 60(1):91-4. PubMed ID: 520420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central cardiovascular action of penicillin in anaesthetized dogs and rats.
    Tsoucaris-Kupfer D; Liblau L; Legrand M; Schmitt H
    Neuropharmacology; 1983 Jul; 22(7):903-6. PubMed ID: 6621819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally mediated cardiovascular effects of nicergoline in the dog compared to those of clonidine.
    Lièvre M; Morin MH; Lakhal M; Faucon G
    Eur J Pharmacol; 1985 Oct; 117(1):103-7. PubMed ID: 4085539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the hypotensive effect of apomorphine].
    Montastruc JL; Guiol C
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs.
    Oyama H; Suzuki Y; Satoh S; Kajita Y; Takayasu M; Shibuya M; Sugita K
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):285-90. PubMed ID: 8436620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
    Montastruc JL; Guiol C; Tran MA; Lhoste F; Montastruc P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):92-103. PubMed ID: 4062436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):132-8. PubMed ID: 7387255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotension produced by intravenous apomorphine in the anaesthetized dog is not centrally mediated.
    Bogaert MG; Buylaert WA; Willems JL
    Br J Pharmacol; 1978 Jul; 63(3):481-4. PubMed ID: 667492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.